Tag: cell therapy human raw materials market share

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Estimated Market Size of the Cell Therapy Human Raw Materials Market In 2029?#_x000D_

The market size for human cell therapy raw materials has seen a substantial increase in the last few years. The forecast projects that this growth will continue, rising from a market worth $2.82 billion in 2024 to $3.36 billion in 2025, indicating a compound annual growth rate (CAGR) of 19.3%. The uptick during the historic period can be traced back to factors like the escalating number of chronic illnesses, an aging population, the surging demand for regenerative medicine, financial backing from the government, and an upward trend in healthcare spending._x000D_

_x000D_

In the coming years, a swift expansion is anticipated in the market size for human raw materials utilized in cell therapy. It’s projected to attain a value of $6.67 billion in 2029, escalating at a compound annual growth rate (CAGR) of 18.7%. The growth prediction for this period is based on multiple factors such as the broadening of therapeutic applications, increased patient understanding, supportive regulation policies, an enlarging biopharmaceutical industry, and advanced manufacturing procedures. Some major trends that will shape this forecast period include the embracement of allogeneic therapies, the incorporation of artificial intelligence, the surge in off-the-shelf cell therapies, the application of 3D bioprinting technology, and the progress in hybrid cell therapies._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Cell Therapy Human Raw Materials Industry?#_x000D_

The growth in the utilization of regenerative medicine is projected to propel the market of cell therapy human raw materials. Utilizing the body’s inherent regenerative properties or external inducements such as stem cells, tissue engineering, or gene therapy to mend, substitute or revitalize harmed tissues and organs, regenerative medicine aims to restore regular function. Its growing visibility can be attributed to progress in biotechnology, an increased awareness of cellular mechanisms, an expanding demand for customized treatment, and the capacity to address medical needs more effectively. By supplying the essential biological components needed for cell-based therapies, cell therapy and human raw materials are endorsing this expansion in regenerative medicine, facilitating the creation of standardized and reliable treatments for a wide array of medical conditions. For instance, in August 2023 a report by the Alliance for Regenerative Medicine, a US-based non-profit organization, indicated that there were 2760 developers of cell, gene, and tissue-engineering therapeutic worldwide in Q1 2023, a 101% increase from 1369 in Q1 2022. Consequently, the burgeoning adoption of regenerative medicine is fueling the market for cell therapy human raw materials._x000D_

_x000D_

#How Is the Cell Therapy Human Raw Materials Market Segmented?#_x000D_

The cell therapy human raw materials market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials_x000D_

2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy_x000D_

3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions_x000D_

_x000D_

Subsegments:_x000D_

1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)_x000D_

2) By Cell Culture Sera: Fetal Bovine Serum (FBS), Human Serum, Adult Bovine Serum_x000D_

3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides_x000D_

4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants_x000D_

5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP), Vials And Storage Containers_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15759&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Cell Therapy Human Raw Materials Market Growth?#_x000D_

North America was the largest region in the cell therapy human raw materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Cell Therapy Human Raw Materials Industry?#_x000D_

Major businesses in the cell therapy human raw materials sector are paying more attention to establishing chemically determined cell culture mediums to boost the progress of cell therapy. Essentially, a cell culture medium is a solution replete with nutrients, crafted to offer the necessary growth components and conditions for cell division and growth outside their natural habitat. To illustrate, in May 2023, Switzerland’s healthcare manufacturing firm, Lonza Group AG, introduced the TheraPEAK T-VIVO Cell Culture Medium. This release is distinctive for its chemically defined formulation, which is serum-free and not composed of animal components. It includes recombinant proteins, provides enhanced culture and expansion support, and assists with application matters, all of which ensure consistency, safety, and compliance with regulations during cell therapy production. The medium represents a significant step forward in technology, owing to the elimination of animal components, its chemically defined formulation, and its regulatory-friendly features. This helps to ensure improved safety, quality, and adherence to regulations._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report_x000D_

_x000D_

#How Is the Cell Therapy Human Raw Materials Market Defined and What Are Its Core Parameters?#_x000D_

Cell therapy human raw materials are biological substances derived from human sources, such as cells, tissues, and blood components, used as foundational elements in the development and manufacturing of cell-based therapeutic products. These raw materials are employed in various stages of cell therapy production to create treatments for diseases such as cancer, genetic disorders, and degenerative conditions._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15759_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Cell Therapy Human Raw Materials Market From 2025 To 2029?

In recent times, the market size for human raw materials in cell therapy has experienced significant expansion. The market is predicted to increase from $2.82 billion in 2024 to $3.39 billion in 2025, boasting a compound annual growth rate (CAGR) of 20.4%. Contributing factors to such growth in the historic period include a heightened incidence of chronic illnesses, an escalating aging population, an increased need for regenerative medicines, state-backed funding and support, as well as skyrocketing healthcare costs.

What Is the Projected Market Size of the Cell Therapy Human Raw Materials Market?

The market size of the raw materials for human cell therapy is predicted to experience dramatic growth in the coming years. It’s expected to reach $7.05 billion by 2029 with a compound annual growth rate (CAGR) of 20.1%. The projected growth within this period can be attributed to the broadening therapeutic applications, heightened patient awareness, favorable regulatory conditions, expansion in the biopharmaceutical industry, and enhancement of manufacturing processes. The forecast period is also expected to see significant trends like the uptake of allogeneic therapies, the incorporation of artificial intelligence, the rise in available off-the-shelf cell therapies, the application of 3D bioprinting technology, and the progression of hybrid cell therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp

Who are the Major Competitors in the Cell Therapy Human Raw Materials Market Outlook?

Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Corning Incorporated, Lonza Group Ltd., Grifols S.A., WuXi AppTec, Catalent Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Pall Corporation, Bio-Techne Corporation, Miltenyi Biotec, Actylis, STEMCELL Technologies, Takara Bio Inc., Vericel Corporation, ACROBiosystems, BioIVT LLC, Orgenesis Inc., PromoCell GMBH, ViaCyte Inc., AllCells LLC, Sartorius CellGenix GmbH, Fujifilm Cellular Dynamics Inc., Mesoblast Limited, RoosterBio Inc., Thermogenesis Holdings Inc.

What Is Fueling Growth in the Cell Therapy Human Raw Materials Market?

The growing embracement of regenerative medicine is anticipated to propel the market for cell therapy human raw materials. Regenerative medicine, which leverages either the body’s innate regenerative capabilities or external stimuli like stem cells, tissue engineering, or gene therapy, focuses on restoring, renewing, or growing new tissues and organs to regain normal functionality. This concept is gaining popularity due to the progress in biotechnology, a heightened comprehension of cellular mechanisms, an increasing interest in personalized medicine, and the capability to adequately cater to unsatisfied medical requirements. Cell therapy and human raw materials are instrumental in promoting regenerative medicine as they provide vital biological ingredients required for cell-based therapies, leading to the creation of standardized and trustworthy treatments for various health problems. To illustrate, in August 2023, a report by the Alliance for Regenerative Medicine, a non-profit entity based in the US, revealed that there were 2760 cell, gene, and tissue-engineering therapy developers globally in Q1 2023, a rise of 101% from 1369 in Q1 2022. Thus, the escalating embrace of regenerative medicine is fueling the cell therapy human raw materials market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15759&type=smp

Which Cell Therapy Human Raw Materials Market Segments Are Growing the Fastest?

The cell therapy human raw materials market covered in this report is segmented –

1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials

2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy

3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions

Subsegments:

1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)

2) By Cell Culture Sera: Fetal Bovine Serum (FBS), Human Serum, Adult Bovine Serum

3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides

4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants

5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP), Vials And Storage Containers

Which Industry Trends Are Shaping the Future of the Cell Therapy Human Raw Materials Market?

In an effort to expedite the advancement of cell therapy, key players in the cell therapy human raw materials market are striving to create chemically structured cell culture mediums. These mediums are nutrient-dense solutions designed to supply vital nutrients, growth elements, and the required environmental conditions for cell growth and propagation beyond their natural surroundings. For instance, TheraPEAK T-VIVO Cell Culture Medium was launched in May 2023 by Lonza Group AG, a healthcare manufacturing company based in Switzerland. The launch of this medium resulted in a significant technological achievement by removing animal components and introducing a chemically defined formulation with regulatory-friendly attributes and application support. Furthermore, it ensures consistency, safety, and regulatory compliance in cell therapy manufacturing, thanks to its serum-free and animal component-free composition and enhanced culture and expansion capabilities. This highly aids in enhancing safety, quality, and regulatory obedience.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

Which Countries Are Leading the Cell Therapy Human Raw Materials Market?

North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15759

This Report Delivers Insight On:

1. How big is the cell therapy human raw materials market, and how is it changing globally?

2. Who are the major companies in the cell therapy human raw materials market, and how are they performing?

3. What are the key opportunities and risks in the cell therapy human raw materials market right now?

4. Which products or customer segments are growing the most in the cell therapy human raw materials market?

5. What factors are helping or slowing down the growth of the cell therapy human raw materials market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the cell therapy human raw materials industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Anticipated CAGR of the Cell Therapy Human Raw Materials Market, and What Factors Will Drive It?

There has been a significant expansion in the market size of human raw materials for cell therapy in the past few years. The projected growth is from $2.82 billion in 2024 to $3.39 billion in 2025, with a compound annual growth rate (CAGR) of 20.4%. Factors contributing to this growth in the historic period include a higher incidence of chronic illnesses, an increasing elderly population, a surge in demand for regenerative medicines, as well as governmental backing and funding, and a rise in healthcare spending.

The market size for human raw materials used in cell therapy is predicted to witness considerable expansion in the coming years, reaching a value of $7.05 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 20.1%. The anticipated expansion during the forecast timeframe can be attributed to factors such as increased applications in therapy, heightened patient awareness, advantageous regulatory environments, the thriving biopharmaceutical industry, and advancements in manufacturing techniques. Key trends during this forecast period are expected to include the increased uptake of allogeneic therapies, the application of AI technology, a rise in off-the-shelf cell therapies, the utilization of 3D bioprinting technology, and advancements in hybrid cell therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Cell Therapy Human Raw Materials Market?

The escalating trend towards regenerative medicine is foreseen to positively impact the cell therapy human raw materials market. This branch of medicine employs the body’s inherent regenerative potential or external stimuli such as stem cells, tissue engineering, or gene therapy, with the goal of repairing, replacing, or regenerating injured tissues and organs to restore regular functionality. Reasons for the growing popularity of regenerative medicine include developments in biotechnology, an enhanced comprehension of cellular mechanisms, increasing demand for personalized medicine, and the ability to cater to unmet medical needs more effectively. By providing the necessary biological components for cell-based therapies, cell therapy and human raw materials aid the increasing acceptance of regenerative medicine, facilitating the creation of standardized, trustworthy treatments for various health issues. For example, a report by the Alliance for Regenerative Medicine, a non-profit organization from the US, disclosed that the number of cell, gene, and tissue-engineering therapeutic developers globally rose by 101% to 2760 in Q1 2023 compared to 1369 in Q1 2022. Thus, the growing incorporation of regenerative medicine significantly fuels the cell therapy human raw materials market.

What Segment Types Define the Cell Therapy Human Raw Materials Market Structure?

The cell therapy human raw materials market covered in this report is segmented –

1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials

2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy

3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions

Subsegments:

1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)

2) By Cell Culture Sera: Fetal Bovine Serum (FBS), Human Serum, Adult Bovine Serum

3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides

4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants

5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP), Vials And Storage Containers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15759&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Cell Therapy Human Raw Materials Market?

North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Cell Therapy Human Raw Materials Industry?

The leading businesses in the cell therapy human raw materials market are consistently aiming to create chemically defined cell culture mediums, a strategy meant to expedite the evolution of cell therapy. A cell culture medium is specifically designed to provide crucial nutrients, proliferative elements, and requisite environmental conditions to foster the in vitro growth of cells outside their native environment. As an example, in May 2023, Lonza Group AG, a health manufacturing company based in Switzerland, unveiled its TheraPEAK T-VIVO Cell Culture Medium. The advantages of this new launch are its chemically defined makeup, absence of serum or animal components, inclusion of recombinant proteins, supported cell culture and expansion, and specific application support, guaranteeing uniformity, safety, and regulatory conformity in manufacturing of cell therapy. The medium is an amalgamation of revolutionary technologies, completely avoiding animal components and adopting a chemically defined formulation, which leads to enhanced safety, quality, and alignment with regulations.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

What Is the Definition of the Cell Therapy Human Raw Materials Market?

Cell therapy human raw materials are biological substances derived from human sources, such as cells, tissues, and blood components, used as foundational elements in the development and manufacturing of cell-based therapeutic products. These raw materials are employed in various stages of cell therapy production to create treatments for diseases such as cancer, genetic disorders, and degenerative conditions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15759

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cell therapy human raw materials market grown over the years?

The cell therapy human raw materials market has seen exponential growth in recent years. It will increase from $2.82 billion in 2024 to $3.39 billion in 2025, reflecting a compound annual growth rate (CAGR) of 20.4%. The growth drivers include the rise in chronic diseases, a growing elderly population, high demand for regenerative medicines, government funding, and an increase in healthcare spending.

What Is the forecasted market size and growth rate for the cell therapy human raw materials market?

The cell therapy human raw materials market is projected to reach $7.05 billion by 2029, growing at a CAGR of 20.1%. Growth is fueled by expanding therapeutic applications, patient awareness, favorable regulatory frameworks, a growing biopharmaceutical sector, and improved manufacturing processes. Trends include allogeneic therapy adoption, AI integration, off-the-shelf cell therapies, 3D bioprinting, and hybrid cell therapy development.

Get your cell therapy human raw materials market report here!

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

What are the major factors driving growth in the cell therapy human raw materials market?

The increasing adoption of regenerative medicine is expected to boost the cell therapy human raw materials market. This field, which aims to repair, replace, or regenerate damaged tissues and organs, benefits from technological advancements, better understanding of cellular processes, a surge in demand for personalized medicine, and its potential to meet unmet medical needs. Cell therapy and human raw materials are key in enabling cell-based treatments, ensuring standardized and reliable therapies for various conditions. For example, a report by the Alliance for Regenerative Medicine in August 2023 indicated that the number of global cell, gene, and tissue-engineering therapeutic developers grew by 101% from 1369 in Q1 2022 to 2760 in Q1 2023. Thus, the rise in regenerative medicine adoption is driving this market.

What key areas define the segmentation of the global cell therapy human raw materials Market?

The cell therapy human raw materials market covered in this report is segmented –

1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials

2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy

3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions

Subsegments:

1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)

2) By Cell Culture Sera: Fetal Bovine Serum (FBS), Human Serum, Adult Bovine Serum

3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides

4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants

5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP), Vials And Storage Containers

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp

What are the top market players propelling the growth of the cell therapy human raw materials industry?

Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Corning Incorporated, Lonza Group Ltd., Grifols S.A., WuXi AppTec, Catalent Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Pall Corporation, Bio-Techne Corporation, Miltenyi Biotec, Actylis, STEMCELL Technologies, Takara Bio Inc., Vericel Corporation, ACROBiosystems, BioIVT LLC, Orgenesis Inc., PromoCell GMBH, ViaCyte Inc., AllCells LLC, Sartorius CellGenix GmbH, Fujifilm Cellular Dynamics Inc., Mesoblast Limited, RoosterBio Inc., Thermogenesis Holdings Inc.

What are the key trends shaping the future of the cell therapy human raw materials market?

In the cell therapy human raw materials market, companies are focusing on the development of chemically defined cell culture mediums to accelerate cell therapy development. These mediums provide essential nutrients and conditions for cells to grow outside their natural environment. For example, in May 2023, Switzerland-based Lonza Group AG launched TheraPEAK T-VIVO Cell Culture Medium, a chemically defined, serum-free medium that ensures consistency, safety, and regulatory compliance in cell therapy manufacturing. The medium eliminates animal components and supports regulatory-friendly practices, improving safety and quality.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15759

What regions are dominating the cell therapy human raw materials market growth?

North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Single Cell Analysis Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market

Basal Cell Carcinoma Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/basal-cell-carcinoma-treatment-global-market-report

Germ Cell Tumor Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/germ-cell-tumor-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Are the Projected Expansion Rates of the Cell Therapy Human Raw Materials Market for the Next Decade?

In recent years, the market size of human raw materials for cell therapy has seen substantial expansion. Its growth is projected to rise from $2.82 billion in 2024 to $3.39 billion in 2025, with a compound annual growth rate (CAGR) of 20.4%. Factors such as the escalating numbers of chronic disease cases, an aging population, an escalating demand for regenerative medicine, government financial aid and backing, as well as increasing healthcare costs, have contributed to the growth experienced in the historical period.

We can anticipate a rapid increase in the cell therapy human raw materials market in the upcoming years, with its worth expected to reach $7.05 billion by 2029, showing an impressive compound annual growth rate (CAGR) of 20.1%. The estimated growth during this forecast period may be credited to the expanded therapeutical uses, heightened patient consciousness, approving regulatory structures, a booming biopharmaceutical industry, and enhanced manufacturing methods. Key trends to look out for during this period include the adoption of allogeneic treatments, the application of artificial intelligence, the upsurge in ready-to-use cell therapies, the deployment of 3D bioprinting techniques, and the creation of hybrid cell therapies.

Which Drivers Are Expected to Have the Greatest Impact on the Cell Therapy Human Raw Materials Market’s Growth?

The cell therapy human raw materials market’s growth is anticipated to be influenced by the increasing acceptance of regenerative medicine. This medicine type, which utilizes the body’s recovery capabilities, stem cells, tissue engineering, or gene therapy, as external triggers, is designed to repair, replace, or regenerate tissues and organs that have been harmed, in an attempt to return to normal functionality. The emergence of regenerative medicine is attributed to advancements in biotechnology, an increased understanding of cell mechanisms, a rising need for customized medicine, and a more efficient way to address unmet medical needs. Cell therapy and human raw materials support the growth of regenerative medicine by supplying critical biological components required for cell-based therapies. This allows for the creation of standardized, dependable treatments for a variety of medical issues. For instance, in August 2023, the Alliance for Regenerative Medicine, a non-profit organization based in the US, reported a 101% increase in the number of cell, gene, and tissue-engineering therapeutic developers worldwide – rising from 1369 in Q1 2022 to 2760 in Q1 2023. Thus, the expansion of regenerative medicine is propelling the cell therapy human raw materials market forward.

Explore Comprehensive Insights Into The Global Cell Therapy Human Raw Materials Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp

Which Companies Are Redefining the Future of the Cell Therapy Human Raw Materials Market?

Major companies operating in the cell therapy human raw materials market are:

• Thermo Fisher Scientific Inc.

• Danaher Corporation

• Merck KGaA

• GE Healthcare

• Corning Incorporated

What Trends Are Poised to Drive the Future Success of the Cell Therapy Human Raw Materials Market?

Leading firms in the cell therapy human raw materials market are progressively centering their efforts on creating chemically structured cell culture mediums. This aim is to hasten the development of cell therapy. A cell culture medium serves as a rich nutrient solution, designed to supply vital nutrients, growth factors, and optimal environmental conditions for in vitro cellular growth and multiplication outside their natural habitat. For instance, in May 2023, TheraPEAK T-VIVO Cell Culture Medium was released by Lonza Group AG, a medical manufacturing company based in Switzerland. The launch presented a chemically defined formulation that was both serum-free and did not contain animal components, as well as included recombinant proteins. It also offered enhanced support for culture and expansion, and application assistance to maintain consistency, safety, and regulatory compliance in cell therapy manufacturing. This medium signifies a considerable technology leap through the removal of animal components, chemically structured formulation, and features suited to regulations. Such contributions promote better safety, quality, and regulatory compliance.

Secure Your Global Cell Therapy Human Raw Materials Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

Which Industry Segments Are Leading the Development and Expansion of the Cell Therapy Human Raw Materials Market?

The cell therapy human raw materials market covered in this report is segmented –

1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials

2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy

3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions

Subsegments:

1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)

2) By Cell Culture Sera: Fetal Bovine Serum (FBS), Human Serum, Adult Bovine Serum

3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides

4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants

5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP), Vials And Storage Containers

What Are the Leading Regions in the Cell Therapy Human Raw Materials Market Expansion?

North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Is the Cell Therapy Human Raw Materials Market Classified and Defined in Market Analysis?

Cell therapy human raw materials are biological substances derived from human sources, such as cells, tissues, and blood components, used as foundational elements in the development and manufacturing of cell-based therapeutic products. These raw materials are employed in various stages of cell therapy production to create treatments for diseases such as cancer, genetic disorders, and degenerative conditions.

Browse Through More Similar Reports By The Business Research Company:

Single Cell Analysis Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market

Basal Cell Carcinoma Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/basal-cell-carcinoma-treatment-global-market-report

Germ Cell Tumor Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/germ-cell-tumor-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: